# COL4A1

## Overview
The COL4A1 gene encodes the collagen type IV alpha 1 chain, a crucial component of type IV collagen, which is a major structural protein in basement membranes. These membranes are essential for maintaining the structural integrity and function of various tissues, including the vasculature, kidneys, and eyes. The protein encoded by COL4A1 is categorized as a structural protein and forms heterotrimers with the COL4A2 chain, contributing to the formation of a complex extracellular matrix network. This network plays a significant role in cell-matrix interactions, cellular signaling, and tissue architecture. Mutations in the COL4A1 gene are linked to a spectrum of clinical disorders, including cerebrovascular diseases, ocular abnormalities, and muscular pathologies, underscoring its importance in human health (Meuwissen2015The; Kuo2012COL4A1; Van2005Dominant).

## Structure
The COL4A1 protein is a component of type IV collagen, a major structural element of basement membranes. It consists of three major domains: an amino-terminal 7S domain, a central triple-helical (collagenous) domain, and a carboxy-terminal non-collagenous (NC1) domain (Kuo2012COL4A1). The primary structure is characterized by Gly-Xaa-Yaa triplet repeats, where Xaa and Yaa are often proline and hydroxyproline, forming a long triple-helical domain (Mao2015Type). The secondary structure involves the interweaving of three alpha chains to form a stiff triple helix (Gale2016A).

The tertiary structure includes interruptions in the Gly-Xaa-Yaa pattern, which confer flexibility and facilitate lateral associations during network assembly (Mao2015Type). These interruptions contain cysteine residues that form interchain cross-linking bridges (Mao2015Type). The quaternary structure involves the formation of heterotrimers with COL4A2, specifically in an α1α1α2 composition (Kuo2012COL4A1). The NC1 domain plays a crucial role in chain selection, assembly, and folding during biosynthesis, forming hexamers through covalent cross-links (Than2002The).

Post-translational modifications include hydroxylation of proline and lysine residues, glycosylation, and the formation of disulfide bonds (Khoshnoodi2008Mammalian). These modifications are essential for the stability and function of the collagen network.

## Function
The COL4A1 gene encodes the alpha-1 chain of type IV collagen, a critical component of basement membranes in various tissues. In healthy human cells, COL4A1 plays a vital role in maintaining the structural integrity and function of basement membranes, which are essential for tissue architecture and cellular communication (Kuo2012COL4A1; Van2005Dominant). The protein forms heterotrimers with COL4A2, which are transported from the endoplasmic reticulum to the Golgi apparatus and then secreted into the extracellular matrix (ECM) (Kuo2012COL4A1). In the ECM, these heterotrimers form higher-order macromolecular networks that provide structural support and facilitate cell-matrix and cell-cell interactions (Kuo2012COL4A1).

COL4A1 is involved in various biological processes, including the formation of the extracellular matrix, angiogenesis, and filtration in the kidneys (Van2005Dominant). The protein interacts with cell surface receptors like integrins, influencing cellular signaling and modulating the distribution of diffusible morphogens (Kuo2012COL4A1). Fragments of type IV collagen, such as arresten, can suppress angiogenesis and tumor growth, highlighting the protein's role in regulating these processes (Kuo2012COL4A1). The proper function of COL4A1 is crucial for maintaining the integrity of basement membranes and supporting various biological processes, including development and homeostasis (Kuo2012COL4A1).

## Clinical Significance
Mutations in the COL4A1 gene are associated with a wide range of clinical conditions, primarily affecting the vascular, neurological, ocular, and muscular systems. These mutations can lead to cerebral small vessel disease, which manifests as porencephaly, a condition characterized by cystic cavities in the brain due to tissue necrosis, often resulting from prenatal and neonatal intracerebral hemorrhage (Meuwissen2015The; Gould2005Mutations). Schizencephaly, characterized by clefts in the brain, is also linked to COL4A1 mutations (Yoneda2012Phenotypic).

COL4A1 mutations are implicated in hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC) syndrome, which includes symptoms such as retinal vessel arterial tortuosity, nephropathy, and muscle cramps (Meuwissen2015The; Alamowitch2009Cerebrovascular). These mutations can also cause ocular abnormalities, including cataracts, anterior segment dysgenesis, and glaucoma (Kuo2012COL4A1).

Muscular manifestations include myopathy, characterized by muscle weakness and elevated creatine kinase levels (LabelleDumais2011COL4A1). COL4A1 mutations are also associated with systemic conditions such as hemolytic anemia and renal disease (Yoneda2012Phenotypic). The pleiotropic nature of COL4A1 mutations results in a broad phenotypic spectrum, affecting multiple organ systems (Kuo2012COL4A1).

## Interactions
The COL4A1 protein, a component of type IV collagen, participates in several critical interactions within the extracellular matrix (ECM). It forms heterotrimers with COL4A2, which are essential for creating macromolecular networks in the ECM. These networks interact with other ECM components such as laminins, perlecans, nidogens, and proteoglycans, providing structural integrity and facilitating cell-matrix and cell-cell communication (Kuo2012COL4A1). 

The noncollagenous (NC1) domain of COL4A1 is involved in the formation of a hexameric structure at the C-terminal junction between two adjacent collagen IV protomers. This structure is stabilized by a novel covalent cross-link between methionine and lysine residues, specifically Met-93 and Lys-211, which is crucial for the stability of the NC1 domain (Than2002The). 

COL4A1 also interacts with cell surface receptors such as integrins, discoidin domain receptors, and heparan sulfate proteoglycans, influencing processes like cell adhesion and migration (Kuo2012COL4A1). Additionally, cleaved fragments of COL4A1, such as arresten, can be biologically active, affecting angiogenesis and tumor growth (Kuo2012COL4A1). These interactions highlight the multifaceted role of COL4A1 in maintaining tissue integrity and regulating cellular functions.


## References


[1. (Mao2015Type) Mao Mao, Marcel V. Alavi, Cassandre Labelle-Dumais, and Douglas B. Gould. Type IV Collagens and Basement Membrane Diseases, pages 61–116. Elsevier, 2015. URL: http://dx.doi.org/10.1016/bs.ctm.2015.09.002, doi:10.1016/bs.ctm.2015.09.002. This article has 68 citations.](https://doi.org/10.1016/bs.ctm.2015.09.002)

[2. (Gale2016A) Daniel P. Gale, D. Deren Oygar, Fujun Lin, P. Derin Oygar, Nadia Khan, Thomas M.F. Connor, Marta Lapsley, Patrick H. Maxwell, and Guy H. Neild. A novelcol4a1frameshift mutation in familial kidney disease: the importance of the c-terminal nc1 domain of type iv collagen. Nephrology Dialysis Transplantation, 31(11):1908–1914, April 2016. URL: http://dx.doi.org/10.1093/ndt/gfw051, doi:10.1093/ndt/gfw051. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/ndt/gfw051)

[3. (Alamowitch2009Cerebrovascular) S. Alamowitch, E. Plaisier, P. Favrole, C. Prost, Z. Chen, T. Van Agtmael, B. Marro, and P. Ronco. Cerebrovascular disease related to col4a1 mutations in hanac syndrome. Neurology, 73(22):1873–1882, December 2009. URL: http://dx.doi.org/10.1212/wnl.0b013e3181c3fd12, doi:10.1212/wnl.0b013e3181c3fd12. This article has 121 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.0b013e3181c3fd12)

[4. (Van2005Dominant) Tom Van Agtmael, Ursula Schlötzer-Schrehardt, Lisa McKie, David G. Brownstein, Angela W. Lee, Sally H. Cross, Yoshikazu Sado, John J. Mullins, Ernst Pöschl, and Ian J. Jackson. Dominant mutations of col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Human Molecular Genetics, 14(21):3161–3168, September 2005. URL: http://dx.doi.org/10.1093/hmg/ddi348, doi:10.1093/hmg/ddi348. This article has 117 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddi348)

[5. (Kuo2012COL4A1) D. S. Kuo, C. Labelle-Dumais, and D. B. Gould. Col4a1 and col4a2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Human Molecular Genetics, 21(R1):R97–R110, August 2012. URL: http://dx.doi.org/10.1093/hmg/dds346, doi:10.1093/hmg/dds346. This article has 236 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/dds346)

[6. (Than2002The) Manuel E. Than, Stefan Henrich, Robert Huber, Albert Ries, Karlheinz Mann, Klaus Kühn, Rupert Timpl, Gleb P. Bourenkov, Hans D. Bartunik, and Wolfram Bode. The 1.9-å crystal structure of the noncollagenous (nc1) domain of human placenta collagen iv shows stabilization via a novel type of covalent met-lys cross-link. Proceedings of the National Academy of Sciences, 99(10):6607–6612, May 2002. URL: http://dx.doi.org/10.1073/pnas.062183499, doi:10.1073/pnas.062183499. This article has 96 citations.](https://doi.org/10.1073/pnas.062183499)

[7. (LabelleDumais2011COL4A1) Cassandre Labelle-Dumais, David J. Dilworth, Emily P. Harrington, Michelle de Leau, David Lyons, Zhyldyz Kabaeva, M. Chiara Manzini, William B. Dobyns, Christopher A. Walsh, Daniel E. Michele, and Douglas B. Gould. Col4a1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and walker-warburg syndrome in humans. PLoS Genetics, 7(5):e1002062, May 2011. URL: http://dx.doi.org/10.1371/journal.pgen.1002062, doi:10.1371/journal.pgen.1002062. This article has 116 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1002062)

[8. (Khoshnoodi2008Mammalian) Jamshid Khoshnoodi, Vadim Pedchenko, and Billy G. Hudson. Mammalian collagen iv. Microscopy Research and Technique, 71(5):357–370, January 2008. URL: http://dx.doi.org/10.1002/jemt.20564, doi:10.1002/jemt.20564. This article has 500 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jemt.20564)

[9. (Yoneda2012Phenotypic) Yuriko Yoneda, Kazuhiro Haginoya, Mitsuhiro Kato, Hitoshi Osaka, Kenji Yokochi, Hiroshi Arai, Akiyoshi Kakita, Takamichi Yamamoto, Yoshiro Otsuki, Shin‐ichi Shimizu, Takahito Wada, Norihisa Koyama, Yoichi Mino, Noriko Kondo, Satoru Takahashi, Shinichi Hirabayashi, Jun‐ichi Takanashi, Akihisa Okumura, Toshiyuki Kumagai, Satori Hirai, Makoto Nabetani, Shinji Saitoh, Ayako Hattori, Mami Yamasaki, Akira Kumakura, Yoshinobu Sugo, Kiyomi Nishiyama, Satoko Miyatake, Yoshinori Tsurusaki, Hiroshi Doi, Noriko Miyake, Naomichi Matsumoto, and Hirotomo Saitsu. Phenotypic spectrum of col4a1 mutations: porencephaly to schizencephaly. Annals of Neurology, 73(1):48–57, December 2012. URL: http://dx.doi.org/10.1002/ana.23736, doi:10.1002/ana.23736. This article has 138 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.23736)

[10. (Meuwissen2015The) Marije E.C. Meuwissen, Dicky J.J. Halley, Liesbeth S. Smit, Maarten H. Lequin, Jan M. Cobben, René de Coo, Jeske van Harssel, Suzanne Sallevelt, Gwendolyn Woldringh, Marjo S. van der Knaap, Linda S. de Vries, and Grazia M.S. Mancini. The expanding phenotype of col4a1 and col4a2 mutations: clinical data on 13 newly identified families and a review of the literature. Genetics in Medicine, 17(11):843–853, November 2015. URL: http://dx.doi.org/10.1038/gim.2014.210, doi:10.1038/gim.2014.210. This article has 215 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/gim.2014.210)

[11. (Gould2005Mutations) Douglas B. Gould, F. Campbell Phalan, Guido J. Breedveld, Saskia E. van Mil, Richard S. Smith, John C. Schimenti, Umberto Aguglia, Marjo S. van der Knaap, Peter Heutink, and Simon W. M. John. Mutations in col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science, 308(5725):1167–1171, May 2005. URL: http://dx.doi.org/10.1126/science.1109418, doi:10.1126/science.1109418. This article has 409 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1109418)